Jianzong Chen

950 total citations
17 papers, 830 citations indexed

About

Jianzong Chen is a scholar working on Molecular Biology, Biochemistry and Pharmacology. According to data from OpenAlex, Jianzong Chen has authored 17 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Biochemistry and 6 papers in Pharmacology. Recurrent topics in Jianzong Chen's work include Medicinal Plants and Bioactive Compounds (12 papers), Biochemical Acid Research Studies (7 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Jianzong Chen is often cited by papers focused on Medicinal Plants and Bioactive Compounds (12 papers), Biochemical Acid Research Studies (7 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Jianzong Chen collaborates with scholars based in China. Jianzong Chen's co-authors include Ruru Li, Xiaojun Zhang, Xiaobing Li, Lizhen Tao, Lingling Zhang, Xin Jia, Juan Zhang, Jinping Zhang, Rongrong Hou and Weifeng Jiang and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Neurochemistry.

In The Last Decade

Jianzong Chen

17 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianzong Chen China 16 516 154 136 124 105 17 830
E-Jian Lee Taiwan 22 414 0.8× 161 1.0× 186 1.4× 122 1.0× 155 1.5× 61 1.3k
Jeong Seon Yoon South Korea 18 547 1.1× 117 0.8× 98 0.7× 60 0.5× 115 1.1× 28 997
Sun‐Young Hwang South Korea 19 412 0.8× 137 0.9× 98 0.7× 73 0.6× 131 1.2× 47 1.2k
Xiu‐Yun Song China 16 388 0.8× 122 0.8× 63 0.5× 131 1.1× 149 1.4× 33 800
Jia Cui China 21 681 1.3× 150 1.0× 73 0.5× 116 0.9× 113 1.1× 51 1.3k
Sachiko Kanai Japan 18 293 0.6× 143 0.9× 169 1.2× 99 0.8× 98 0.9× 73 1.2k
Yuxia Xu China 14 379 0.7× 108 0.7× 70 0.5× 50 0.4× 90 0.9× 29 768
Baojian Guo China 16 260 0.5× 94 0.6× 119 0.9× 76 0.6× 106 1.0× 26 674
Shu Yu China 16 487 0.9× 88 0.6× 64 0.5× 81 0.7× 118 1.1× 28 778
Zian Xia China 18 573 1.1× 55 0.4× 138 1.0× 137 1.1× 88 0.8× 30 938

Countries citing papers authored by Jianzong Chen

Since Specialization
Citations

This map shows the geographic impact of Jianzong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianzong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianzong Chen more than expected).

Fields of papers citing papers by Jianzong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianzong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianzong Chen. The network helps show where Jianzong Chen may publish in the future.

Co-authorship network of co-authors of Jianzong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jianzong Chen. A scholar is included among the top collaborators of Jianzong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianzong Chen. Jianzong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Li, Ruru, Tao Li, Yan Fang, et al.. (2019). Salidroside Protects Dopaminergic Neurons by Preserving Complex I Activity via DJ-1/Nrf2-Mediated Antioxidant Pathway. Parkinson s Disease. 2019. 1–10. 26 indexed citations
2.
Li, Tao, Wei Zhang, Xiaogang Kang, et al.. (2019). Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D‐ND6 pathway in the MPTP/MPP+‐induced model of Parkinson's disease. Journal of Neurochemistry. 153(2). 276–289. 24 indexed citations
3.
Li, Ruru & Jianzong Chen. (2019). Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. Oxidative Medicine and Cellular Longevity. 2019. 1–11. 63 indexed citations
4.
Li, Tao, Feng Yang, Ruixin Yang, et al.. (2018). Salidroside Promotes the Pathological α-Synuclein Clearance Through Ubiquitin-Proteasome System in SH-SY5Y Cells. Frontiers in Pharmacology. 9. 377–377. 29 indexed citations
5.
Xu, Hang, Liang Cao, Tao Li, et al.. (2017). Salidroside Protects against MPP+‐Induced Neuronal Injury through DJ‐1‐Nrf2 Antioxidant Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 5398542–5398542. 16 indexed citations
6.
Zhao, Junjie, et al.. (2016). Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson’s Disease: Involvement of the PI3K/Akt/GSK3βPathway. Parkinson s Disease. 2016. 1–9. 39 indexed citations
8.
Jiang, Lin, Le Wang, Lei Chen, et al.. (2015). As2O3 induces apoptosis in human hepatocellular carcinoma HepG2 cells through a ROS-mediated mitochondrial pathway and activation of caspases.. PubMed. 8(2). 2190–6. 31 indexed citations
9.
Chen, Lei, et al.. (2014). Protective Effects of Salidroside in the MPTP/MPP+-Induced Model of Parkinson's Disease through ROS–NO-Related Mitochondrion Pathway. Molecular Neurobiology. 51(2). 718–728. 80 indexed citations
10.
Zhang, Lingling, Linhong Huang, Liang-Wei Chen, Dingjun Hao, & Jianzong Chen. (2013). Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. Toxicology Letters. 222(2). 155–163. 40 indexed citations
11.
Zhang, Jinkang, Liu Yang, Guolin Meng, et al.. (2013). Protection by Salidroside against Bone Loss via Inhibition of Oxidative Stress and Bone-Resorbing Mediators. PLoS ONE. 8(2). e57251–e57251. 77 indexed citations
12.
Zhang, Lingling, Wenjun Ding, Qiong Zhou, et al.. (2012). Salidroside protects PC12 cells from MPP+-induced apoptosis via activation of the PI3K/Akt pathway. Food and Chemical Toxicology. 50(8). 2591–2597. 48 indexed citations
13.
Tao, Lizhen, Xiaofeng Li, Lingling Zhang, et al.. (2011). Protective Effect of Tetrahydroxystilbene Glucoside on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway. PLoS ONE. 6(10). e26055–e26055. 55 indexed citations
14.
Li, Xiaofeng, Xiaoli Ye, Xiaobing Li, et al.. (2011). Salidroside protects against MPP+-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain Research. 1382. 9–18. 56 indexed citations
15.
Li, Xiaobing, Gang Li, Lizhen Tao, et al.. (2011). Protection by tetrahydroxystilbene glucoside against neurotoxicity induced by MPP+: The involvement of PI3K/Akt pathway activation. Toxicology Letters. 202(1). 1–7. 71 indexed citations
16.
Zhang, Jinping, Anheng Liu, Rongrong Hou, et al.. (2009). Salidroside protects cardiomyocyte against hypoxia-induced death: A HIF-1α-activated and VEGF-mediated pathway. European Journal of Pharmacology. 607(1-3). 6–14. 135 indexed citations
17.
Huang, Yuan‐Gui, Jianzong Chen, Lei Ma, et al.. (2007). Effects of Topiramate on Mouse Eccrine Sweat Gland Responsiveness to Heat Exposure. Basic & Clinical Pharmacology & Toxicology. 100(6). 377–382. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026